drugset / Trial / NCT07106918
A Clinical Trial of SIBP-A16 Injection in Healthy Adults
RandomizedParallel-groupQuadruple-blindPrevention
Summary
This study is a randomized, double-blind, placebo/positive control Phase Ia clinical trial evaluating the safety, tolerability, and pharmacokinetics of SIBP-A16 injection in healthy adults
Timeline
- Start
- 2025-08-17
- Primary completion
- 2027-04-30
- Completion
- 2027-04-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Nirsevimab | Monoclonal antibody | — | Intramuscular |
| Subject | SIBP-A16 injection | Unknown | — | Intramuscular |